Therapeutic strategies based on stimulation of the sGC-cGMP pathway in animal models of COPD have shown, in addition to attenuating the loss of muscle mass, reductions in cigarette smoke-induced oxidative stress (7, 19). The gene discussed is SGCB; the disease is chronic obstructive pulmonary disease.